Publication | Closed Access
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
121
Citations
0
References
2018
Year
Viral PersistenceViral HepatitisAntiviral TherapyHepatitisMyrcludex BOpen-label Phase 2BInfection ControlAntiviral DrugChronic Viral InfectionMedicineFinal Results
No additional data available for this publication yet. Check back later!